PFE vs ABBV
PFE 与 ABBV 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | PFEPFIZER INC | ABBVAbbVie Inc. |
|---|---|---|
| 市值 | $173.84B | $520.97B |
| 市盈率(TTM) | 40.1 | 83.3 |
| 市净率 | 2.04 | — |
| 市销率 | 2.8x | 8.5x |
| 股息率 | 5.62% | 2.24% |
| 营收 | $63.70B(TTM) | $61.16B(TTM) |
| 营收同比增长 | -1.6% | 8.6% |
| 净利润 | $4.33B(TTM) | $6.31B(TTM) |
| 净利同比增长 | -3.2% | -1.2% |
| 每股收益(稀释) | $0.76(TTM) | $3.54(TTM) |
| 息税前利润率 | 16.3% | 24.6% |
| 净资产收益率 | 9.1% | — |
| 投入资本回报率 | 6.9% | 18.6% |
| 一年总回报 | +32.6% | +32.0% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:PFE vs ABBV
| 指标 | PFE | ABBV |
|---|---|---|
| 期末价值 | $13.8K | $73.0K |
| 总回报 | +38.5% | +629.9% |
| 年化收益 (CAGR) | +3.2% | +21.2% |
| 波动率 | 23.9% | 25.8% |
| 夏普比率 | 0.08 | 0.72 |
| 索提诺比率 | 0.11 | 1.00 |
| 最大回撤 | -59.0% | -45.1% |
基于 2600 个共同交易日,2016-06-29 → 2026-10-30 · 无风险利率 4.16%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)